Matthias Manne Knopp

Title: Matthias Manne Knopp: Innovator in Viral Treatment Formulations

Introduction

Matthias Manne Knopp is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of viral infections. With a total of two patents to his name, Knopp is recognized for his innovative approaches to addressing pressing health challenges.

Latest Patents

Knopp's latest patents focus on niclosamide formulations for treating diseases associated with SARS-CoV-2. The inventions detail a method of treating viral infections by administering a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin. This method can be administered by inhalation, intraorally, and/or intranasally, showcasing a novel approach to combating viral infections.

Career Highlights

Knopp is currently associated with Union Therapeutics A/S, where he continues to develop innovative solutions in the pharmaceutical industry. His work is pivotal in the ongoing fight against viral diseases, particularly in the context of the global pandemic.

Collaborations

Some of his notable coworkers include Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. Their collaborative efforts contribute to the advancement of research and development in the field of therapeutics.

Conclusion

Matthias Manne Knopp stands out as an influential inventor in the realm of viral treatment formulations. His innovative work and collaborations are essential in the ongoing efforts to develop effective therapies for viral infections.